Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The role of autologous natural killer cells in chronic myelogenous leukemia.
Leuk Lymphoma. 1997 Nov;27(5-6):387-99. doi: 10.3109/10428199709058306.
Leuk Lymphoma. 1997.
PMID: 9477121
Review.
Natural killer cell proliferation is dependent on human serum and markedly increased utilizing an enriched supplemented basal medium.
Pierson BA, McGlave PB, Hu WS, Miller JS.
Pierson BA, et al.
J Hematother. 1995 Jun;4(3):149-58. doi: 10.1089/scd.1.1995.4.149.
J Hematother. 1995.
PMID: 7551914
Item in Clipboard
Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors.
Pierson BA, Gupta K, Hu WS, Miller JS.
Pierson BA, et al.
Blood. 1996 Jan 1;87(1):180-9.
Blood. 1996.
PMID: 8547640
Free article.
Item in Clipboard
Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
Cervantes F, Pierson BA, McGlave PB, Verfaillie CM, Miller JS.
Cervantes F, et al. Among authors: pierson ba.
Blood. 1996 Mar 15;87(6):2476-85.
Blood. 1996.
PMID: 8630414
Free article.
Item in Clipboard
CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis.
Pierson BA, Miller JS.
Pierson BA, et al.
Blood. 1996 Sep 15;88(6):2279-87.
Blood. 1996.
PMID: 8822949
Free article.
Item in Clipboard
Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor.
Pierson BA, Europa AF, Hu WS, Miller JS.
Pierson BA, et al.
J Hematother. 1996 Oct;5(5):475-83. doi: 10.1089/scd.1.1996.5.475.
J Hematother. 1996.
PMID: 8938519
Item in Clipboard
Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J Jr, Burns LJ.
Miller JS, et al. Among authors: pierson ba.
Biol Blood Marrow Transplant. 1997 Apr;3(1):34-44.
Biol Blood Marrow Transplant. 1997.
PMID: 9209739
Clinical Trial.
Item in Clipboard
Population dynamics of human activated natural killer cells in culture.
Pierson BA, Miller JS, Verfaillie C, McGlave PB, Hu WS.
Pierson BA, et al.
Biotechnol Bioeng. 1994 Apr 5;43(8):685-92. doi: 10.1002/bit.260430803.
Biotechnol Bioeng. 1994.
PMID: 18615792
Item in Clipboard
Cite
Cite